MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 191 filers reported holding MYRIAD GENETICS INC in Q1 2020. The put-call ratio across all filers is 2.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $307 | -99.9% | 21,139 | +75.6% | 0.03% | -13.9% |
| Q1 2022 | $303,000 | +30.6% | 12,040 | -41.1% | 0.04% | +2.9% |
| Q2 2020 | $232,000 | +24.7% | 20,426 | +56.9% | 0.04% | -2.8% |
| Q1 2020 | $186,000 | -79.5% | 13,016 | -33.9% | 0.04% | -71.4% |
| Q3 2018 | $906,000 | +143.5% | 19,694 | +97.7% | 0.13% | +125.0% |
| Q2 2018 | $372,000 | -10.4% | 9,962 | -17.6% | 0.06% | -24.3% |
| Q4 2017 | $415,000 | +11.6% | 12,083 | -33.1% | 0.07% | -26.0% |
| Q3 2016 | $372,000 | -35.3% | 18,058 | -3.9% | 0.10% | -35.9% |
| Q2 2016 | $575,000 | – | 18,787 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |